Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Express Scripts Earnings Surged 74%; Forecast Clears Lowered Hurdle

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/18/2013 | 11:18pm CEST
   By Jon Kamp 
 

Pharmacy-benefit manager Express Scripts Holding Co. (>> Express Scripts Holding Co) reported a 74% surge in fourth-quarter earnings, helped by a major acquisition, while forecasting 2013 earnings mostly ahead of a Wall Street target the company helped drag lower three months ago.

The St. Louis-based company--which manages drug-benefit programs for health plans and corporate customers--rattled analysts in November when it said their forecasts for 2013 looked too high. Express Scripts didn't release its own guidance at the time, but said a still-weak economy was weighing on the number of prescriptions it handles.

Monday's release finally included company guidance for adjusted earnings of $4.20 to $4.30 per share this year. The target is largely above the $4.20 forecast among analysts surveyed by Thomson Reuters, although Express Scripts' November warning caused analysts to trim the consensus forecast by about 30 cents since then.

This will mark the first full year of combined operations for Express Scripts and Medco Health Solutions, which created the largest pharmacy-benefit manager, or PBM, following April's $29.1 billion Medco acquisition.

"2012 was a monumental year for Express Scripts as we closed the acquisition of Medco and made significant progress integrating the two companies," George Paz, Express Scripts' chief executive, said in a press release.

The company plans to hold a conference call Tuesday morning. Its shares are up about 2.9% so far this year, through Friday's close, trailing a 6.6% gain in the Standard & Poor's 500 index.

The company reported fourth-quarter earnings of $504.1 million, or 61 cents a share, up from $290.4 million, or 59 cents a share, a year earlier. Excluding deal-related costs and other items, per-share earnings rose to $1.05 from 82 cents.

Revenue more than doubled to $27.41 billion from the year-earlier period, which was before the Medco deal.

Analysts surveyed by Thomson Reuters had forecast earnings of $1.04 a share on sales of $27.24 billion. Analysts are forecasting lower sales in coming quarters as health insurer UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) brings in-house the PBM business it had outsourced to Medco.

Express Scripts saw adjusted claims--a measure that takes into account monthly prescriptions filled in retail pharmacies and 90-day fills through the company's mail-order business--rise 111% in the recent quarter to 410.8 million.

The company's full-year adjusted claims tally about matched its target by nearing 1.4 billion. The company expects 5% to 7% growth in adjusted claims this year.

Its adjusted earnings forecast represents 12% to 15% growth.

Write to Jon Kamp at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Express Scripts Holding Co, UnitedHealth Group Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPRESS SCRIPTS HOLDING CO
05/28 EXPRESS SCRIPTS : St. Louis firms deny short-seller's allegation of 'murky allia..
05/24 EXPRESS SCRIPTS : Insulin cost speeds away and diabetic Hoosiers are forced to m..
05/23 EXPRESS SCRIPTS HOLDING COMPANY (NAS : ESRX) Files An 8-K Departure of Directors..
05/23 EXPRESS SCRIPTS HOLDING CO. : Change in Directors or Principal Officers (form 8-..
05/18 EXPRESS SCRIPTS HOLDING COMPANY (NAS : ESRX) Interested In Workers’ Compen..
05/18 EXPRESS SCRIPTS : Subsidiary to Join Walgreens Boots Alliance Development Group ..
05/18 EXPRESS SCRIPTS : acquires Florida firm
05/17 EXPRESS SCRIPTS : and myMatrixx Combine To Offer Best-in-Class Pharmacy Services..
05/13 SANOFI : New Programs Aim to Curb Diabetes Drug Costs
05/12 EXPRESS SCRIPTS HOLDING COMPANY (NAS : ESRX) Files An 8-K Submission of Matters ..
More news
Sector news : Drug Retailers - NEC
05/17DJCVS HEALTH : Why Your Pharmacy May Be Texting You -- WSJ
05/15 SHANGHAI PHARMACEUTICALS : Advent, Shanghai Pharma have not approached Stada - s..
05/02 CVS HEALTH : profit beats as pharmacy margins rise
05/02DJCVS HEALTH : Profit Declines in First Quarter of 'Rebuilding Year'
04/26 PayPal's profit, revenue beat on higher processing volumes
More sector news : Drug Retailers - NEC
News from SeekingAlpha
05/19 Express Scripts Holding (ESRX) Presents At BofAML 2017 Global Metals, Mining ..
05/19 EXPRESS SCRIPTS AND MALLLINCKRODT : In Case Chanos Is Right
05/19 Tracking Glenn Greenberg's Brave Warrior Advisors Portfolio - Q1 2017 Update
05/18 Chanos pitches shorts of Mallinckrodt and Express Scripts at SALT
05/17 Express Scripts buys workers comp-focused pharmacy benefits provider myMatrix..
Advertisement
Financials ($)
Sales 2017 101 582 M
EBIT 2017 7 031 M
Net income 2017 3 088 M
Debt 2017 11 219 M
Yield 2017 -
P/E ratio 2017 11,30
P/E ratio 2018 10,12
EV / Sales 2017 0,46x
EV / Sales 2018 0,44x
Capitalization 35 875 M
More Financials
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Full-screen chart
Technical analysis trends EXPRESS SCRIPTS H...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 65,9 $
Spread / Average Target 10%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Chief Operating Officer & Executive Vice President
Eric R. Slusser Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDIN..-13.13%35 875
WALGREENS BOOTS ALLIAN..-1.82%87 827
CVS HEALTH CORP-2.88%78 080
MCKESSON CORPORATION14.77%33 997
CARDINAL HEALTH INC1.57%23 091
AMERISOURCEBERGEN CORP..16.38%19 870
More Results